{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:39:03Z","timestamp":1791923943331,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Laboratory Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.plabm.2025.e00472","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:46:36Z","timestamp":1746099996000},"page":"e00472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Biotin interference in routine clinical immunoassays"],"prefix":"10.1016","volume":"45","author":[{"given":"Kuo-Chun","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Rong","family":"Jhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ni","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Kang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Hui","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Pin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-I","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plabm.2025.e00472_bib1","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/clinchem\/40.11.1996","article-title":"Interference with clinical laboratory analyses","volume":"40","author":"Kroll","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.plabm.2025.e00472_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0004563217701777","article-title":"Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays","volume":"55","author":"Trambas","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.plabm.2025.e00472_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1373\/jalm.2017.024257","article-title":"Biotin interference in clinical immunoassays","volume":"2","author":"Colon","year":"2018","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.plabm.2025.e00472_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0188-4409(02)00399-5","article-title":"Biotin in metabolism and its relationship to human disease","volume":"33","author":"Pacheco-Alvarez","year":"2002","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.plabm.2025.e00472_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4155\/ipk-2017-0013","article-title":"Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference","volume":"2","author":"Grimsey","year":"2017","journal-title":"Int. J. Pharmacokinet."},{"key":"10.1016\/j.plabm.2025.e00472_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0004563220961759","article-title":"Biotin immunoassay interference: a UK-based prevalence study","volume":"58","author":"Sanders","year":"2021","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.plabm.2025.e00472_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clinbiochem.2020.05.009","article-title":"Prevalence of detectable biotin in The Netherlands in relation to risk on immunoassay interference","volume":"83","author":"Ijpelaar","year":"2020","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.plabm.2025.e00472_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clinbiochem.2019.01.004","article-title":"Further assessment of the prevalence of biotin supplementation and its impact on risk","volume":"65","author":"Trambas","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.plabm.2025.e00472_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinbiochem.2018.07.004","article-title":"Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department","volume":"60","author":"Katzman","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.plabm.2025.e00472_bib10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2017.13705","article-title":"Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults","volume":"318","author":"Li","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.plabm.2025.e00472_bib11","first-page":"989","article-title":"Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks, Endocr","volume":"23","author":"Samarasinghe","year":"2017","journal-title":"In Pract."},{"key":"10.1016\/j.plabm.2025.e00472_bib12","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/ajcp\/aqx115.015","article-title":"Systematic analysis of biotin interference in Roche chemistry assays","volume":"149","author":"Muthukumar","year":"2018","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.plabm.2025.e00472_bib13","series-title":"FDA Warns that Biotin May Interfere with Lab Tests","year":"2017"},{"key":"10.1016\/j.plabm.2025.e00472_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMc1602096","article-title":"Biotin treatment mimicking Graves' disease","volume":"375","author":"Kummer","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plabm.2025.e00472_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000184381","article-title":"Serum biotin levels in patients undergoing chronic hemodialysis","volume":"46","author":"Livaniou","year":"1987","journal-title":"Nephron"},{"key":"10.1016\/j.plabm.2025.e00472_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cca.2018.10.013","article-title":"Comprehensive assessment of biotin interference in immunoassays","volume":"487","author":"Li","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.plabm.2025.e00472_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/cclm-2016-1183","article-title":"High-dose biotin therapy leading to false biochemical endocrine profiles: Validation of a simple method to overcome biotin interference","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2025.e00472_bib18","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.5858\/arpa.2019-0425-OA","article-title":"Interference from high-dose biotin intake in immunoassays for potentially time-critical analytes by Roche","volume":"144","author":"Mrosewski","year":"2020","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.plabm.2025.e00472_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clinbiochem.2021.10.011","article-title":"Serum biotin interference: a troublemaker in hormone immunoassays","volume":"99","author":"\u00d6nc\u00fcl","year":"2022","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.plabm.2025.e00472_bib20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1089\/thy.2020.0866","article-title":"Biotin interference in assays for thyroid hormones, thyrotropin and thyroglobulin","volume":"31","author":"Ylli","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.plabm.2025.e00472_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jalm\/jfz010","article-title":"AACC guidance document on biotin interference in laboratory tests","volume":"5","author":"Li","year":"2020","journal-title":"J. Appl. Lab. Med."}],"container-title":["Practical Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551725000253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551725000253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:43:13Z","timestamp":1762620193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352551725000253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":21,"alternative-id":["S2352551725000253"],"URL":"https:\/\/doi.org\/10.1016\/j.plabm.2025.e00472","relation":{},"ISSN":["2352-5517"],"issn-type":[{"value":"2352-5517","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biotin interference in routine clinical immunoassays","name":"articletitle","label":"Article Title"},{"value":"Practical Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plabm.2025.e00472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00472"}}